Do diabetes, metabolic syndrome or their association equally affect biventricular function A tissue Doppler study

Francesco Paneni, Mario Gregori, Giuliano Tocci, Francesca Palano, Giuseppino Massimo Ciavarella, Giulia Pignatelli, Andrea Marra, Sebastiano Sciarretta, Andrea Ferrucci, Massimo Volpe

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Metabolic syndrome (MetS) and type 2 diabetes (T2DM) have been associated with an impairment of left (LV) and right ventricular (RV) function as well as an increased risk of heart failure (HF). However, it remains unclear whether these clinical entities or their associations promote a similar derangement of biventricular function. Overall, 345 patients without overt cardiovascular disease consecutively underwent routine blood chemistry including high-sensitivity C reactive protein (hs-CRP) and echocardiographical examination with conventional and tissue Doppler imaging (TDI) of both ventricles. According to the ATP III criteria and fasting glucose levels, the study population was stratified into four groups: (1) healthy controls (n=120); (2) MetS without T2DM (n=84); (3) T2DM without MetS (n=49); and (4) MetS+T2DM (n=92). The Myocardial performance index (MPI) of the RV and LV was obtained with a multi-segmental approach using TDI. Patients with MetS and T2DM exhibited a similar impairment of biventricular function compared with healthy controls, whereas a further decline was observed in patients having both MetS and T2DM. In addition to MetS markers, hs-CRP exhibited the strongest association with the MPI of both ventricles. Regression analyses indicated that individual MetS markers were inferior to MetS in identifying subtle cardiac dysfunction. Independent associations of MetS and T2DM with biventricular dysfunction were comparable, and the coexistence of MetS and T2DM exhibited the highest risk for biventricular dysfunction. Our findings emphasize the importance of MetS as an equivalent of T2DM and support a synergic effect of these clinical conditions on cardiac organ damage requiring more aggressive therapeutic strategies to prevent HF.

Original languageEnglish
Pages (from-to)36-42
Number of pages7
JournalHypertension Research
Volume36
Issue number1
DOIs
Publication statusPublished - Jan 2013

Fingerprint

C-Reactive Protein
Heart Failure
Right Ventricular Function
Left Ventricular Function
Type 2 Diabetes Mellitus
Fasting
Cardiovascular Diseases
Adenosine Triphosphate
Regression Analysis
Glucose
Population
Therapeutics

Keywords

  • biventricular dysfunction
  • diabetes
  • heart failure
  • metabolic syndrome
  • tissue Doppler imaging

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Do diabetes, metabolic syndrome or their association equally affect biventricular function A tissue Doppler study. / Paneni, Francesco; Gregori, Mario; Tocci, Giuliano; Palano, Francesca; Ciavarella, Giuseppino Massimo; Pignatelli, Giulia; Marra, Andrea; Sciarretta, Sebastiano; Ferrucci, Andrea; Volpe, Massimo.

In: Hypertension Research, Vol. 36, No. 1, 01.2013, p. 36-42.

Research output: Contribution to journalArticle

Paneni, Francesco ; Gregori, Mario ; Tocci, Giuliano ; Palano, Francesca ; Ciavarella, Giuseppino Massimo ; Pignatelli, Giulia ; Marra, Andrea ; Sciarretta, Sebastiano ; Ferrucci, Andrea ; Volpe, Massimo. / Do diabetes, metabolic syndrome or their association equally affect biventricular function A tissue Doppler study. In: Hypertension Research. 2013 ; Vol. 36, No. 1. pp. 36-42.
@article{33bba4e21a7742d2bcb8519ff94fd491,
title = "Do diabetes, metabolic syndrome or their association equally affect biventricular function A tissue Doppler study",
abstract = "Metabolic syndrome (MetS) and type 2 diabetes (T2DM) have been associated with an impairment of left (LV) and right ventricular (RV) function as well as an increased risk of heart failure (HF). However, it remains unclear whether these clinical entities or their associations promote a similar derangement of biventricular function. Overall, 345 patients without overt cardiovascular disease consecutively underwent routine blood chemistry including high-sensitivity C reactive protein (hs-CRP) and echocardiographical examination with conventional and tissue Doppler imaging (TDI) of both ventricles. According to the ATP III criteria and fasting glucose levels, the study population was stratified into four groups: (1) healthy controls (n=120); (2) MetS without T2DM (n=84); (3) T2DM without MetS (n=49); and (4) MetS+T2DM (n=92). The Myocardial performance index (MPI) of the RV and LV was obtained with a multi-segmental approach using TDI. Patients with MetS and T2DM exhibited a similar impairment of biventricular function compared with healthy controls, whereas a further decline was observed in patients having both MetS and T2DM. In addition to MetS markers, hs-CRP exhibited the strongest association with the MPI of both ventricles. Regression analyses indicated that individual MetS markers were inferior to MetS in identifying subtle cardiac dysfunction. Independent associations of MetS and T2DM with biventricular dysfunction were comparable, and the coexistence of MetS and T2DM exhibited the highest risk for biventricular dysfunction. Our findings emphasize the importance of MetS as an equivalent of T2DM and support a synergic effect of these clinical conditions on cardiac organ damage requiring more aggressive therapeutic strategies to prevent HF.",
keywords = "biventricular dysfunction, diabetes, heart failure, metabolic syndrome, tissue Doppler imaging",
author = "Francesco Paneni and Mario Gregori and Giuliano Tocci and Francesca Palano and Ciavarella, {Giuseppino Massimo} and Giulia Pignatelli and Andrea Marra and Sebastiano Sciarretta and Andrea Ferrucci and Massimo Volpe",
year = "2013",
month = "1",
doi = "10.1038/hr.2012.137",
language = "English",
volume = "36",
pages = "36--42",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Do diabetes, metabolic syndrome or their association equally affect biventricular function A tissue Doppler study

AU - Paneni, Francesco

AU - Gregori, Mario

AU - Tocci, Giuliano

AU - Palano, Francesca

AU - Ciavarella, Giuseppino Massimo

AU - Pignatelli, Giulia

AU - Marra, Andrea

AU - Sciarretta, Sebastiano

AU - Ferrucci, Andrea

AU - Volpe, Massimo

PY - 2013/1

Y1 - 2013/1

N2 - Metabolic syndrome (MetS) and type 2 diabetes (T2DM) have been associated with an impairment of left (LV) and right ventricular (RV) function as well as an increased risk of heart failure (HF). However, it remains unclear whether these clinical entities or their associations promote a similar derangement of biventricular function. Overall, 345 patients without overt cardiovascular disease consecutively underwent routine blood chemistry including high-sensitivity C reactive protein (hs-CRP) and echocardiographical examination with conventional and tissue Doppler imaging (TDI) of both ventricles. According to the ATP III criteria and fasting glucose levels, the study population was stratified into four groups: (1) healthy controls (n=120); (2) MetS without T2DM (n=84); (3) T2DM without MetS (n=49); and (4) MetS+T2DM (n=92). The Myocardial performance index (MPI) of the RV and LV was obtained with a multi-segmental approach using TDI. Patients with MetS and T2DM exhibited a similar impairment of biventricular function compared with healthy controls, whereas a further decline was observed in patients having both MetS and T2DM. In addition to MetS markers, hs-CRP exhibited the strongest association with the MPI of both ventricles. Regression analyses indicated that individual MetS markers were inferior to MetS in identifying subtle cardiac dysfunction. Independent associations of MetS and T2DM with biventricular dysfunction were comparable, and the coexistence of MetS and T2DM exhibited the highest risk for biventricular dysfunction. Our findings emphasize the importance of MetS as an equivalent of T2DM and support a synergic effect of these clinical conditions on cardiac organ damage requiring more aggressive therapeutic strategies to prevent HF.

AB - Metabolic syndrome (MetS) and type 2 diabetes (T2DM) have been associated with an impairment of left (LV) and right ventricular (RV) function as well as an increased risk of heart failure (HF). However, it remains unclear whether these clinical entities or their associations promote a similar derangement of biventricular function. Overall, 345 patients without overt cardiovascular disease consecutively underwent routine blood chemistry including high-sensitivity C reactive protein (hs-CRP) and echocardiographical examination with conventional and tissue Doppler imaging (TDI) of both ventricles. According to the ATP III criteria and fasting glucose levels, the study population was stratified into four groups: (1) healthy controls (n=120); (2) MetS without T2DM (n=84); (3) T2DM without MetS (n=49); and (4) MetS+T2DM (n=92). The Myocardial performance index (MPI) of the RV and LV was obtained with a multi-segmental approach using TDI. Patients with MetS and T2DM exhibited a similar impairment of biventricular function compared with healthy controls, whereas a further decline was observed in patients having both MetS and T2DM. In addition to MetS markers, hs-CRP exhibited the strongest association with the MPI of both ventricles. Regression analyses indicated that individual MetS markers were inferior to MetS in identifying subtle cardiac dysfunction. Independent associations of MetS and T2DM with biventricular dysfunction were comparable, and the coexistence of MetS and T2DM exhibited the highest risk for biventricular dysfunction. Our findings emphasize the importance of MetS as an equivalent of T2DM and support a synergic effect of these clinical conditions on cardiac organ damage requiring more aggressive therapeutic strategies to prevent HF.

KW - biventricular dysfunction

KW - diabetes

KW - heart failure

KW - metabolic syndrome

KW - tissue Doppler imaging

UR - http://www.scopus.com/inward/record.url?scp=84872066410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872066410&partnerID=8YFLogxK

U2 - 10.1038/hr.2012.137

DO - 10.1038/hr.2012.137

M3 - Article

C2 - 22951523

AN - SCOPUS:84872066410

VL - 36

SP - 36

EP - 42

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 1

ER -